Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Rodríguez, Daniel
Formiga, Francesc
Fort, Isabel
Robles, María José
Barranco, Elena
and
Cubí, Dolors
2012.
Tratamiento farmacológico de la demencia: cuándo, cómo y hasta cuándo. Recomendaciones del Grupo de Trabajo de Demencias de la Sociedad Catalana de Geriatría y Gerontología.
Revista Española de Geriatría y Gerontología,
Vol. 47,
Issue. 5,
p.
228.
Schwarz, Stefan
Froelich, Lutz
and
Burns, Alistair
2012.
Pharmacological treatment of dementia.
Current Opinion in Psychiatry,
Vol. 25,
Issue. 6,
p.
542.
Wolter, Dirk K.
2012.
Was man mit und ohne Medikamente erreicht.
MMW - Fortschritte der Medizin,
Vol. 154,
Issue. 7,
p.
85.
Schneider, Lon S.
2012.
Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease.
New England Journal of Medicine,
Vol. 366,
Issue. 10,
p.
957.
Guillemaud, C.
Faucounau, V.
Greffard, S.
and
Verny, M.
2013.
Tratamiento de la demencia.
EMC - Tratado de Medicina,
Vol. 17,
Issue. 4,
p.
1.
Saleh, Solin
Kirk, Andrew
Morgan, Debra G.
and
Karunanayake, Chandima
2013.
Less Education Predicts Anticholinesterase Discontinuation in Dementia Patients.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 40,
Issue. 5,
p.
684.
Hogan, David B
2014.
Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease.
The Canadian Journal of Psychiatry,
Vol. 59,
Issue. 12,
p.
618.
Viloria Jiménez, A.
2014.
Enfermedades neurológicas y psiquiátricas en el anciano.
Medicine - Programa de Formación Médica Continuada Acreditado,
Vol. 11,
Issue. 62,
p.
3659.
Rockwood, Kenneth
2014.
For How Long Should We Use Symptomatic Therapies to Treat People with Alzheimer Disease?.
The Canadian Journal of Psychiatry,
Vol. 59,
Issue. 12,
p.
615.
Gardette, Virginie
Lapeyre-Mestre, Maryse
Piau, Antoine
Gallini, Adeline
Cantet, Christelle
Montastruc, Jean-Louis
Vellas, Bruno
and
Andrieu, Sandrine
2014.
A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe.
CNS Drugs,
Vol. 28,
Issue. 2,
p.
157.
Parsons, Carole
2016.
Withdrawal of Antidementia Drugs in Older People: Who, When and How?.
Drugs & Aging,
Vol. 33,
Issue. 8,
p.
545.
Wong, Chit Wai
2016.
Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
Drugs & Aging,
Vol. 33,
Issue. 7,
p.
451.
Deardorff, William James
and
Grossberg, George T.
2016.
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease.
Expert Opinion on Pharmacotherapy,
Vol. 17,
Issue. 13,
p.
1789.
Petit, A.-E.
Mangeard, H.
Chazard, E.
and
Puisieux, F.
2017.
Évolution de la prise en charge médicamenteuse de la maladie d’Alzheimer en EHPAD : impact de la campagne médiatique contre les médicaments spécifiques de la maladie d’Alzheimer.
L'Encéphale,
Vol. 43,
Issue. 1,
p.
21.
Hager, Klaus
and
Krause, Olaf
2017.
Absetzen von Cholinesterasehemmern.
DNP - Der Neurologe & Psychiater,
Vol. 18,
Issue. 4,
p.
20.
Maclagan, Laura C.
Bronskill, Susan E.
Guan, Jun
Campitelli, Michael A.
Herrmann, Nathan
Lapane, Kate L.
Hogan, David B.
Amuah, Joseph E.
Seitz, Dallas P.
Gill, Sudeep S.
and
Maxwell, Colleen J.
2018.
Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission.
Journal of the American Medical Directors Association,
Vol. 19,
Issue. 11,
p.
959.
Hong, Yun Jeong
Choi, Seong Hye
Jeong, Jee Hyang
Park, Kyung Won
Na, Hae Ri
and
Seo, Sang-Won
2018.
Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study.
Journal of Alzheimer's Disease,
Vol. 63,
Issue. 3,
p.
1035.
Moraes, Flávia Silva de
Souza, Mariana Lima Cerqueira de
Lucchetti, Giancarlo
and
Lucchetti, Alessandra Lamas Granero
2018.
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis.
Arquivos de Neuro-Psiquiatria,
Vol. 76,
Issue. 7,
p.
444.
Hager, K.
Temps, T.
and
Krause, O.
2019.
Antidementiva, Antidepressiva und Neuroleptika bei alten Patienten absetzen.
Medizinische Klinik - Intensivmedizin und Notfallmedizin,
Vol. 114,
Issue. 5,
p.
463.
Oh, Seung-Taek
Han, Kyu-Tae
Choi, Won-Jung
and
Park, Jaesub
2019.
Effect of drug compliance on health care costs in newly-diagnosed dementia: Analysis of nationwide population-based data.
Journal of Psychiatric Research,
Vol. 118,
Issue. ,
p.
31.